Kerem Doga Seckin
Istanbul, Turkey (Türkiye)
NCT Number: NCT03229304
The aim of the study is to evaluate the uterine artery doppler just before labour in term low risk pregnancies. And to investigate with this measurement if investigators could foreseen the amount of postpartum hemorrhage looking at decreased in the hematocrit values.
Looking for future studies?
Notify Me18 year–40 year
Female
Observational
Istanbul, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
the pregnant women who have
Time frame: 6-8 hour before the delivery
With ultrasonography uterine artery doppler Pulsatility index (cm/s) will be measure
Time frame: 6-8 hour before the delivery
With ultrasonography uterine artery doppler Resistant index will be measure
Time frame: 6-8 hour before the delivery
With ultrasonography Uterine artery doppler Mean systolic/diastolic volume (cm/s) ) will be measure
Kanuni Sultan Suleyman Training and Research Hospital
Other
The Role of Uterine Artery Doppler Measurement to Predict the Amount of Postpartum Hemorrhage in Low Risk Term Pregnancy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06192836
Cesarean Section Complications, Dystocia
Ankara, Turkey (Türkiye)
View Trial DetailsNCT06635564
Bleeding Disorder, Brain Diseases
Vienna, Austria
View Trial DetailsNCT03120208
Depression, Postpartum, Depressive Disorder
Clermont-Ferrand, France
View Trial DetailsNCT07689136
Cardiovascular Diseases, Deep Vein Thrombosis
Tunis, Tunisia
View Trial Details